Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multicenter Study for the Assessment of Biomarker Signatures for the Diagnosis of Pulmonary Hypertension (PH) in Patients at Low or Intermediate Probability of PH Undergoing Cardiac Magnetic Resonance Imaging (MRI) CIPHER-MRI

NCT04480723 is registered in ClinicalTrials.gov with Actelion as lead sponsor.

NCT NCT04480723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04480723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multicenter Study for the Assessment of Biomarker Signatures for the Diagnosis of Pulmonary Hypertension (PH) in Patients at Low or Intermediate Probability of PH Undergoing Cardiac Magnetic Resonance Imaging (MRI) CIPHER-MRI
Lead sponsor
Actelion
Phase
Phase 1
Overall status
Completed
Start date
December 11, 2020
Completion date
May 18, 2022
Enrollment
86 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, pulmonary